iRhythm Technologies Inc (STU:I25)
€ 79.5 -2 (-2.45%) Market Cap: 2.51 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 37.70 GF Score: 68/100

iRhythm Technologies Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 05:35PM GMT
Release Date Price: €89 (-3.78%)
Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate

Well, great. Thank you for coming, everyone. I'm Kallum Titchmarsh, medical device analyst here at Morgan Stanley. Really pleased today to be joined by the iRhythm team. We've got Quentin Blackford, CEO, and we've got Dan Wilson, here from IR.

Just before we get started, a couple of quick disclosures for you. Please see Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures or please reach out to your Morgan Stanley sales rep.

Questions & Answers

Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate

Quentin, as we're just chatting a couple of years now as CEO, curious to hear what's occupying the majority of the time at the moment and how that's changed?

Quentin S. Blackford
iRhythm Technologies, Inc. - President, CEO & Director

Sure. It's hard to believe it's been 2 years

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot